Literature DB >> 8725856

Impaired glucose tolerance, diabetes, and cardiovascular disease risk factor profiles in the elderly. The Honolulu Heart Program.

B L Rodriguez1, J D Curb, C M Burchfiel, B Huang, D S Sharp, G Y Lu, W Fujimoto, K Yano.   

Abstract

OBJECTIVE: The relationship between glucose tolerance status and other cardiovascular disease (CVD) risk factors was evaluated in a cohort of Japanese-American men (n = 3,741) ages 71-93 years who participated in the fourth examination of the Honolulu Heart Program in 1991-1993. RESEARCH DESIGN AND METHODS: In this cross-sectional study, subjects were classified by reported diabetes and glucose tolerance status using questionnaires and the World Health Organization (WHO) criteria, respectively.
RESULTS: The prevalence of reported diabetes was 17%. Among the men who completed an oral glucose tolerance test and had no history of diabetes (n = 1,900), 23% were diagnosed as diabetic and 39% had impaired glucose tolerance (IGT) by WHO criteria. The CVD risk factor profiles of men with IGT and diabetes were significantly more adverse compared with men with normal glucose tolerance after adjustment for age. The rates of hypertension, mean levels of BMI, waist-to-hip ratio, triglycerides, and fasting insulin were higher in men with IGT and diabetes compared with normal subjects. Opposite trends were observed for HDL cholesterol. Two-hour insulin was significantly higher among men with IGT and previously undiagnosed diabetes. Men with known diabetes had a lower physical activity index and higher fibrinogen levels than normal subjects. No significant differences were observed for current smoking and alcohol intake. Differences in risk factor levels by glucose tolerance status remained after adjustment for age, physical activity, BMI, and waist-to-hip ratio.
CONCLUSIONS: These findings show that among elderly men of Japanese ancestry, impaired glucose tolerance and undiagnosed and known diabetes are highly prevalent, and these conditions are associated with adverse CVD factor profiles.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8725856     DOI: 10.2337/diacare.19.6.587

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  16 in total

Review 1.  Endothelial dysfunction, inflammation and diabetes.

Authors:  Paresh Dandona; Ahmad Aljada; Ajay Chaudhuri; Priya Mohanty
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

2.  Effect of walking distance on 8-year incident depressive symptoms in elderly men with and without chronic disease: the Honolulu-Asia Aging Study.

Authors:  Toby L Smith; Kamal H Masaki; Kaon Fong; Robert D Abbott; George W Ross; Helen Petrovitch; Patricia L Blanchette; Lon R White
Journal:  J Am Geriatr Soc       Date:  2010-07-28       Impact factor: 5.562

3.  Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program.

Authors:  Robert Ratner; Ronald Goldberg; Steven Haffner; Santica Marcovina; Trevor Orchard; Sarah Fowler; Marinella Temprosa
Journal:  Diabetes Care       Date:  2005-04       Impact factor: 19.112

4.  Increased risk for cardiovascular outcomes and effect of cholesterol-lowering pravastatin therapy in patients with diabetes mellitus in the pravastatin anti-atherosclerosis trial in the elderly (PATE).

Authors:  Toshitsugu Ishikawa; Hideki Ito; Yasuyoshi Ouchi; Yasuo Ohashi; Yasushi Saito; Haruo Nakamura; Hajime Orimo
Journal:  Curr Ther Res Clin Exp       Date:  2005-01

5.  Hyperglycemia, impaired glucose tolerance and elevated glycated hemoglobin levels in a long-lived mouse stock.

Authors:  James M Harper; Stephen J Durkee; Michael Smith-Wheelock; Richard A Miller
Journal:  Exp Gerontol       Date:  2005-04       Impact factor: 4.032

6.  Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance.

Authors:  Steven Haffner; Marinella Temprosa; Jill Crandall; Sarah Fowler; Ronald Goldberg; Edward Horton; Santica Marcovina; Kieren Mather; Trevor Orchard; Robert Ratner; Elizabeth Barrett-Connor
Journal:  Diabetes       Date:  2005-05       Impact factor: 9.461

7.  Use of the dietary supplement 5-aminiolevulinic acid (5-ALA) and its relationship with glucose levels and hemoglobin A1C among individuals with prediabetes.

Authors:  Beatriz L Rodriguez; J David Curb; James Davis; Terry Shintani; Michael H Perez; Noelani Apau-Ludlum; Crystal Johnson; Rosanne C Harrigan
Journal:  Clin Transl Sci       Date:  2012-06-01       Impact factor: 4.689

Review 8.  Age-associated changes in immune and inflammatory responses: impact of vitamin E intervention.

Authors:  Dayong Wu; Simin Nikbin Meydani
Journal:  J Leukoc Biol       Date:  2008-07-02       Impact factor: 4.962

9.  Do risk factors explain the increased prevalence of type 2 diabetes among California Asian adults?

Authors:  Sarah E Choi; Vincent H Chow; Sarah J Chung; Nathan D Wong
Journal:  J Immigr Minor Health       Date:  2011-10

10.  Hypertension and its related factors in Taiwanese elderly people.

Authors:  S W Lai; T C Li; C C Lin; C K Tan; K C Ng; M M Lai; C S Liu
Journal:  Yale J Biol Med       Date:  2001 Mar-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.